Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477838 · ClinicalTrials.gov registry record · NA
Pharmacist-driven CGM Use in the Uninsured Population
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03477838 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 28 participants.
The verdict
NCT03477838, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.
Interventions
- DEVICE FreeStyle LibrePro CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-04-26 |
| Est. Completion | 2019-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03477838
The ClinicalTrials.gov registry entry for NCT03477838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle LibrePro CGM is the first listed.
NCT03477838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03477838 about?
NCT03477838 is a clinical study titled "Pharmacist-driven CGM Use in the Uninsured Population". This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.
What is the current status of trial NCT03477838?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-04-26. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT03477838?
The interventions under investigation include: FreeStyle LibrePro CGM (DEVICE).
Who is sponsoring clinical trial NCT03477838?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.